“The current predicament has uncovered some structural weaknesses in the EU’s medicines provide chain as well as a higher dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides claimed. She recommended that provide chain troubles be addressed in an EU pharmaceutical approach anticipated to become introduced by the t